Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group.
Ueoka H, Tanimoto M, Kiura K, Tabata M, Takigawa N, Segawa Y, Takata I, Eguchi K, Okimoto N, Harita S, Kamei H, Shibayama T, Watanabe Y, Hiraki S, Harada M. Ueoka H, et al. Among authors: harita s. Br J Cancer. 2001 Jul 6;85(1):9-13. doi: 10.1054/bjoc.2001.1861. Br J Cancer. 2001. PMID: 11437395 Free PMC article. Clinical Trial.
[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Tada A, Ueoka H, Kiura K, Tabata M, Takemoto M, Yamane H, Hiyama J, Aoe K, Shibayama T, Kamei H, Kawahara S, Harita S, Sato T, Kobayashi M, Eguchi K, Hiraki S, Hiraki Y, Tanimoto M. Tada A, et al. Among authors: harita s. Gan To Kagaku Ryoho. 2002 May;29(5):751-6. Gan To Kagaku Ryoho. 2002. PMID: 12040679 Clinical Trial. Japanese.
Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer.
Kiura K, Ueoka H, Segawa Y, Tabata M, Kamei H, Takigawa N, Hiraki S, Watanabe Y, Bessho A, Eguchi K, Okimoto N, Harita S, Takemoto M, Hiraki Y, Harada M, Tanimoto M; Okayama Lung Cancer Study Group. Kiura K, et al. Among authors: harita s. Br J Cancer. 2003 Sep 1;89(5):795-802. doi: 10.1038/sj.bjc.6601217. Br J Cancer. 2003. PMID: 12942107 Free PMC article. Clinical Trial.
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.
Hotta K, Kiura K, Tabata M, Harita S, Gemba K, Yonei T, Bessho A, Maeda T, Moritaka T, Shibayama T, Matsuo K, Kato K, Kanehiro A, Tanimoto Y, Matsuo K, Ueoka H, Tanimoto M. Hotta K, et al. Among authors: harita s. Cancer J. 2005 Sep-Oct;11(5):417-24. doi: 10.1097/00130404-200509000-00010. Cancer J. 2005. PMID: 16259873
62 results